Medical Care
Engineered T Cells - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Sep 18, 24
- ID: 550749
- Pages: 111
- Figures: 176
- Views: 1
The global market for Engineered T Cells was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Engineered T Cells was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Engineered T Cells was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Engineered T Cells was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Engineered T Cells include Autolus Limited, Bellicum Pharmaceuticals, Cells Medica, Elli Lilly and Company, Gilead Sciences, Juno Therapeutics, Novartis, Oxford Biomedica and Pfizer, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Engineered T Cells, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Engineered T Cells by region & country, by Type, and by Application.
The Engineered T Cells market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Engineered T Cells.
Market Segmentation
By Company
Autolus Limited
Bellicum Pharmaceuticals
Cells Medica
Elli Lilly and Company
Gilead Sciences
Juno Therapeutics
Novartis
Oxford Biomedica
Pfizer
Precision Bioscience
Redmile Group
Seeking Alpha
Unum Therapeutics
Segment by Type:
Tumor Infiltrating Lymphocytes
T Cell Receptor {TCR}
Chimeric Antigen Receptor(CAR)
Segment by Application
Hospitals
Cancer Research Centers
Clinics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Engineered T Cells manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Engineered T Cells in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Engineered T Cells in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
North American market for Engineered T Cells was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Engineered T Cells was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Engineered T Cells was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Engineered T Cells include Autolus Limited, Bellicum Pharmaceuticals, Cells Medica, Elli Lilly and Company, Gilead Sciences, Juno Therapeutics, Novartis, Oxford Biomedica and Pfizer, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Engineered T Cells, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Engineered T Cells by region & country, by Type, and by Application.
The Engineered T Cells market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Engineered T Cells.
Market Segmentation
By Company
Autolus Limited
Bellicum Pharmaceuticals
Cells Medica
Elli Lilly and Company
Gilead Sciences
Juno Therapeutics
Novartis
Oxford Biomedica
Pfizer
Precision Bioscience
Redmile Group
Seeking Alpha
Unum Therapeutics
Segment by Type:
Tumor Infiltrating Lymphocytes
T Cell Receptor {TCR}
Chimeric Antigen Receptor(CAR)
Segment by Application
Hospitals
Cancer Research Centers
Clinics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Engineered T Cells manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Engineered T Cells in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Engineered T Cells in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Engineered T Cells Product Introduction
1.2 Global Engineered T Cells Market Size Forecast
1.3 Engineered T Cells Market Trends & Drivers
1.3.1 Engineered T Cells Industry Trends
1.3.2 Engineered T Cells Market Drivers & Opportunity
1.3.3 Engineered T Cells Market Challenges
1.3.4 Engineered T Cells Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Engineered T Cells Players Revenue Ranking (2023)
2.2 Global Engineered T Cells Revenue by Company (2019-2024)
2.3 Key Companies Engineered T Cells Manufacturing Base Distribution and Headquarters
2.4 Key Companies Engineered T Cells Product Offered
2.5 Key Companies Time to Begin Mass Production of Engineered T Cells
2.6 Engineered T Cells Market Competitive Analysis
2.6.1 Engineered T Cells Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Engineered T Cells Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Engineered T Cells as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Tumor Infiltrating Lymphocytes
3.1.2 T Cell Receptor {TCR}
3.1.3 Chimeric Antigen Receptor(CAR)
3.2 Global Engineered T Cells Sales Value by Type
3.2.1 Global Engineered T Cells Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Engineered T Cells Sales Value, by Type (2019-2030)
3.2.3 Global Engineered T Cells Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Cancer Research Centers
4.1.3 Clinics
4.2 Global Engineered T Cells Sales Value by Application
4.2.1 Global Engineered T Cells Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Engineered T Cells Sales Value, by Application (2019-2030)
4.2.3 Global Engineered T Cells Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Engineered T Cells Sales Value by Region
5.1.1 Global Engineered T Cells Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Engineered T Cells Sales Value by Region (2019-2024)
5.1.3 Global Engineered T Cells Sales Value by Region (2025-2030)
5.1.4 Global Engineered T Cells Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Engineered T Cells Sales Value, 2019-2030
5.2.2 North America Engineered T Cells Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Engineered T Cells Sales Value, 2019-2030
5.3.2 Europe Engineered T Cells Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Engineered T Cells Sales Value, 2019-2030
5.4.2 Asia Pacific Engineered T Cells Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Engineered T Cells Sales Value, 2019-2030
5.5.2 South America Engineered T Cells Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Engineered T Cells Sales Value, 2019-2030
5.6.2 Middle East & Africa Engineered T Cells Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Engineered T Cells Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Engineered T Cells Sales Value
6.3 United States
6.3.1 United States Engineered T Cells Sales Value, 2019-2030
6.3.2 United States Engineered T Cells Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Engineered T Cells Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Engineered T Cells Sales Value, 2019-2030
6.4.2 Europe Engineered T Cells Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Engineered T Cells Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Engineered T Cells Sales Value, 2019-2030
6.5.2 China Engineered T Cells Sales Value by Type (%), 2023 VS 2030
6.5.3 China Engineered T Cells Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Engineered T Cells Sales Value, 2019-2030
6.6.2 Japan Engineered T Cells Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Engineered T Cells Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Engineered T Cells Sales Value, 2019-2030
6.7.2 South Korea Engineered T Cells Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Engineered T Cells Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Engineered T Cells Sales Value, 2019-2030
6.8.2 Southeast Asia Engineered T Cells Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Engineered T Cells Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Engineered T Cells Sales Value, 2019-2030
6.9.2 India Engineered T Cells Sales Value by Type (%), 2023 VS 2030
6.9.3 India Engineered T Cells Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Autolus Limited
7.1.1 Autolus Limited Profile
7.1.2 Autolus Limited Main Business
7.1.3 Autolus Limited Engineered T Cells Products, Services and Solutions
7.1.4 Autolus Limited Engineered T Cells Revenue (US$ Million) & (2019-2024)
7.1.5 Autolus Limited Recent Developments
7.2 Bellicum Pharmaceuticals
7.2.1 Bellicum Pharmaceuticals Profile
7.2.2 Bellicum Pharmaceuticals Main Business
7.2.3 Bellicum Pharmaceuticals Engineered T Cells Products, Services and Solutions
7.2.4 Bellicum Pharmaceuticals Engineered T Cells Revenue (US$ Million) & (2019-2024)
7.2.5 Bellicum Pharmaceuticals Recent Developments
7.3 Cells Medica
7.3.1 Cells Medica Profile
7.3.2 Cells Medica Main Business
7.3.3 Cells Medica Engineered T Cells Products, Services and Solutions
7.3.4 Cells Medica Engineered T Cells Revenue (US$ Million) & (2019-2024)
7.3.5 Elli Lilly and Company Recent Developments
7.4 Elli Lilly and Company
7.4.1 Elli Lilly and Company Profile
7.4.2 Elli Lilly and Company Main Business
7.4.3 Elli Lilly and Company Engineered T Cells Products, Services and Solutions
7.4.4 Elli Lilly and Company Engineered T Cells Revenue (US$ Million) & (2019-2024)
7.4.5 Elli Lilly and Company Recent Developments
7.5 Gilead Sciences
7.5.1 Gilead Sciences Profile
7.5.2 Gilead Sciences Main Business
7.5.3 Gilead Sciences Engineered T Cells Products, Services and Solutions
7.5.4 Gilead Sciences Engineered T Cells Revenue (US$ Million) & (2019-2024)
7.5.5 Gilead Sciences Recent Developments
7.6 Juno Therapeutics
7.6.1 Juno Therapeutics Profile
7.6.2 Juno Therapeutics Main Business
7.6.3 Juno Therapeutics Engineered T Cells Products, Services and Solutions
7.6.4 Juno Therapeutics Engineered T Cells Revenue (US$ Million) & (2019-2024)
7.6.5 Juno Therapeutics Recent Developments
7.7 Novartis
7.7.1 Novartis Profile
7.7.2 Novartis Main Business
7.7.3 Novartis Engineered T Cells Products, Services and Solutions
7.7.4 Novartis Engineered T Cells Revenue (US$ Million) & (2019-2024)
7.7.5 Novartis Recent Developments
7.8 Oxford Biomedica
7.8.1 Oxford Biomedica Profile
7.8.2 Oxford Biomedica Main Business
7.8.3 Oxford Biomedica Engineered T Cells Products, Services and Solutions
7.8.4 Oxford Biomedica Engineered T Cells Revenue (US$ Million) & (2019-2024)
7.8.5 Oxford Biomedica Recent Developments
7.9 Pfizer
7.9.1 Pfizer Profile
7.9.2 Pfizer Main Business
7.9.3 Pfizer Engineered T Cells Products, Services and Solutions
7.9.4 Pfizer Engineered T Cells Revenue (US$ Million) & (2019-2024)
7.9.5 Pfizer Recent Developments
7.10 Precision Bioscience
7.10.1 Precision Bioscience Profile
7.10.2 Precision Bioscience Main Business
7.10.3 Precision Bioscience Engineered T Cells Products, Services and Solutions
7.10.4 Precision Bioscience Engineered T Cells Revenue (US$ Million) & (2019-2024)
7.10.5 Precision Bioscience Recent Developments
7.11 Redmile Group
7.11.1 Redmile Group Profile
7.11.2 Redmile Group Main Business
7.11.3 Redmile Group Engineered T Cells Products, Services and Solutions
7.11.4 Redmile Group Engineered T Cells Revenue (US$ Million) & (2019-2024)
7.11.5 Redmile Group Recent Developments
7.12 Seeking Alpha
7.12.1 Seeking Alpha Profile
7.12.2 Seeking Alpha Main Business
7.12.3 Seeking Alpha Engineered T Cells Products, Services and Solutions
7.12.4 Seeking Alpha Engineered T Cells Revenue (US$ Million) & (2019-2024)
7.12.5 Seeking Alpha Recent Developments
7.13 Unum Therapeutics
7.13.1 Unum Therapeutics Profile
7.13.2 Unum Therapeutics Main Business
7.13.3 Unum Therapeutics Engineered T Cells Products, Services and Solutions
7.13.4 Unum Therapeutics Engineered T Cells Revenue (US$ Million) & (2019-2024)
7.13.5 Unum Therapeutics Recent Developments
8 Industry Chain Analysis
8.1 Engineered T Cells Industrial Chain
8.2 Engineered T Cells Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Engineered T Cells Sales Model
8.5.2 Sales Channel
8.5.3 Engineered T Cells Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Engineered T Cells Product Introduction
1.2 Global Engineered T Cells Market Size Forecast
1.3 Engineered T Cells Market Trends & Drivers
1.3.1 Engineered T Cells Industry Trends
1.3.2 Engineered T Cells Market Drivers & Opportunity
1.3.3 Engineered T Cells Market Challenges
1.3.4 Engineered T Cells Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Engineered T Cells Players Revenue Ranking (2023)
2.2 Global Engineered T Cells Revenue by Company (2019-2024)
2.3 Key Companies Engineered T Cells Manufacturing Base Distribution and Headquarters
2.4 Key Companies Engineered T Cells Product Offered
2.5 Key Companies Time to Begin Mass Production of Engineered T Cells
2.6 Engineered T Cells Market Competitive Analysis
2.6.1 Engineered T Cells Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Engineered T Cells Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Engineered T Cells as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Tumor Infiltrating Lymphocytes
3.1.2 T Cell Receptor {TCR}
3.1.3 Chimeric Antigen Receptor(CAR)
3.2 Global Engineered T Cells Sales Value by Type
3.2.1 Global Engineered T Cells Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Engineered T Cells Sales Value, by Type (2019-2030)
3.2.3 Global Engineered T Cells Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Cancer Research Centers
4.1.3 Clinics
4.2 Global Engineered T Cells Sales Value by Application
4.2.1 Global Engineered T Cells Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Engineered T Cells Sales Value, by Application (2019-2030)
4.2.3 Global Engineered T Cells Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Engineered T Cells Sales Value by Region
5.1.1 Global Engineered T Cells Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Engineered T Cells Sales Value by Region (2019-2024)
5.1.3 Global Engineered T Cells Sales Value by Region (2025-2030)
5.1.4 Global Engineered T Cells Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Engineered T Cells Sales Value, 2019-2030
5.2.2 North America Engineered T Cells Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Engineered T Cells Sales Value, 2019-2030
5.3.2 Europe Engineered T Cells Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Engineered T Cells Sales Value, 2019-2030
5.4.2 Asia Pacific Engineered T Cells Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Engineered T Cells Sales Value, 2019-2030
5.5.2 South America Engineered T Cells Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Engineered T Cells Sales Value, 2019-2030
5.6.2 Middle East & Africa Engineered T Cells Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Engineered T Cells Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Engineered T Cells Sales Value
6.3 United States
6.3.1 United States Engineered T Cells Sales Value, 2019-2030
6.3.2 United States Engineered T Cells Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Engineered T Cells Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Engineered T Cells Sales Value, 2019-2030
6.4.2 Europe Engineered T Cells Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Engineered T Cells Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Engineered T Cells Sales Value, 2019-2030
6.5.2 China Engineered T Cells Sales Value by Type (%), 2023 VS 2030
6.5.3 China Engineered T Cells Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Engineered T Cells Sales Value, 2019-2030
6.6.2 Japan Engineered T Cells Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Engineered T Cells Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Engineered T Cells Sales Value, 2019-2030
6.7.2 South Korea Engineered T Cells Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Engineered T Cells Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Engineered T Cells Sales Value, 2019-2030
6.8.2 Southeast Asia Engineered T Cells Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Engineered T Cells Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Engineered T Cells Sales Value, 2019-2030
6.9.2 India Engineered T Cells Sales Value by Type (%), 2023 VS 2030
6.9.3 India Engineered T Cells Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Autolus Limited
7.1.1 Autolus Limited Profile
7.1.2 Autolus Limited Main Business
7.1.3 Autolus Limited Engineered T Cells Products, Services and Solutions
7.1.4 Autolus Limited Engineered T Cells Revenue (US$ Million) & (2019-2024)
7.1.5 Autolus Limited Recent Developments
7.2 Bellicum Pharmaceuticals
7.2.1 Bellicum Pharmaceuticals Profile
7.2.2 Bellicum Pharmaceuticals Main Business
7.2.3 Bellicum Pharmaceuticals Engineered T Cells Products, Services and Solutions
7.2.4 Bellicum Pharmaceuticals Engineered T Cells Revenue (US$ Million) & (2019-2024)
7.2.5 Bellicum Pharmaceuticals Recent Developments
7.3 Cells Medica
7.3.1 Cells Medica Profile
7.3.2 Cells Medica Main Business
7.3.3 Cells Medica Engineered T Cells Products, Services and Solutions
7.3.4 Cells Medica Engineered T Cells Revenue (US$ Million) & (2019-2024)
7.3.5 Elli Lilly and Company Recent Developments
7.4 Elli Lilly and Company
7.4.1 Elli Lilly and Company Profile
7.4.2 Elli Lilly and Company Main Business
7.4.3 Elli Lilly and Company Engineered T Cells Products, Services and Solutions
7.4.4 Elli Lilly and Company Engineered T Cells Revenue (US$ Million) & (2019-2024)
7.4.5 Elli Lilly and Company Recent Developments
7.5 Gilead Sciences
7.5.1 Gilead Sciences Profile
7.5.2 Gilead Sciences Main Business
7.5.3 Gilead Sciences Engineered T Cells Products, Services and Solutions
7.5.4 Gilead Sciences Engineered T Cells Revenue (US$ Million) & (2019-2024)
7.5.5 Gilead Sciences Recent Developments
7.6 Juno Therapeutics
7.6.1 Juno Therapeutics Profile
7.6.2 Juno Therapeutics Main Business
7.6.3 Juno Therapeutics Engineered T Cells Products, Services and Solutions
7.6.4 Juno Therapeutics Engineered T Cells Revenue (US$ Million) & (2019-2024)
7.6.5 Juno Therapeutics Recent Developments
7.7 Novartis
7.7.1 Novartis Profile
7.7.2 Novartis Main Business
7.7.3 Novartis Engineered T Cells Products, Services and Solutions
7.7.4 Novartis Engineered T Cells Revenue (US$ Million) & (2019-2024)
7.7.5 Novartis Recent Developments
7.8 Oxford Biomedica
7.8.1 Oxford Biomedica Profile
7.8.2 Oxford Biomedica Main Business
7.8.3 Oxford Biomedica Engineered T Cells Products, Services and Solutions
7.8.4 Oxford Biomedica Engineered T Cells Revenue (US$ Million) & (2019-2024)
7.8.5 Oxford Biomedica Recent Developments
7.9 Pfizer
7.9.1 Pfizer Profile
7.9.2 Pfizer Main Business
7.9.3 Pfizer Engineered T Cells Products, Services and Solutions
7.9.4 Pfizer Engineered T Cells Revenue (US$ Million) & (2019-2024)
7.9.5 Pfizer Recent Developments
7.10 Precision Bioscience
7.10.1 Precision Bioscience Profile
7.10.2 Precision Bioscience Main Business
7.10.3 Precision Bioscience Engineered T Cells Products, Services and Solutions
7.10.4 Precision Bioscience Engineered T Cells Revenue (US$ Million) & (2019-2024)
7.10.5 Precision Bioscience Recent Developments
7.11 Redmile Group
7.11.1 Redmile Group Profile
7.11.2 Redmile Group Main Business
7.11.3 Redmile Group Engineered T Cells Products, Services and Solutions
7.11.4 Redmile Group Engineered T Cells Revenue (US$ Million) & (2019-2024)
7.11.5 Redmile Group Recent Developments
7.12 Seeking Alpha
7.12.1 Seeking Alpha Profile
7.12.2 Seeking Alpha Main Business
7.12.3 Seeking Alpha Engineered T Cells Products, Services and Solutions
7.12.4 Seeking Alpha Engineered T Cells Revenue (US$ Million) & (2019-2024)
7.12.5 Seeking Alpha Recent Developments
7.13 Unum Therapeutics
7.13.1 Unum Therapeutics Profile
7.13.2 Unum Therapeutics Main Business
7.13.3 Unum Therapeutics Engineered T Cells Products, Services and Solutions
7.13.4 Unum Therapeutics Engineered T Cells Revenue (US$ Million) & (2019-2024)
7.13.5 Unum Therapeutics Recent Developments
8 Industry Chain Analysis
8.1 Engineered T Cells Industrial Chain
8.2 Engineered T Cells Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Engineered T Cells Sales Model
8.5.2 Sales Channel
8.5.3 Engineered T Cells Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Engineered T Cells Market Trends
Table 2. Engineered T Cells Market Drivers & Opportunity
Table 3. Engineered T Cells Market Challenges
Table 4. Engineered T Cells Market Restraints
Table 5. Global Engineered T Cells Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Engineered T Cells Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Engineered T Cells Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Engineered T Cells Product Type
Table 9. Key Companies Time to Begin Mass Production of Engineered T Cells
Table 10. Global Engineered T Cells Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Engineered T Cells as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Engineered T Cells Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Engineered T Cells Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Engineered T Cells Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Engineered T Cells Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Engineered T Cells Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Engineered T Cells Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Engineered T Cells Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Engineered T Cells Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Engineered T Cells Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Engineered T Cells Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Engineered T Cells Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Engineered T Cells Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Engineered T Cells Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Engineered T Cells Sales Value by Region (2019-2024) & (%)
Table 27. Global Engineered T Cells Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Engineered T Cells Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Engineered T Cells Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Engineered T Cells Sales Value, (2025-2030) & (US$ Million)
Table 31. Autolus Limited Basic Information List
Table 32. Autolus Limited Description and Business Overview
Table 33. Autolus Limited Engineered T Cells Products, Services and Solutions
Table 34. Revenue (US$ Million) in Engineered T Cells Business of Autolus Limited (2019-2024)
Table 35. Autolus Limited Recent Developments
Table 36. Bellicum Pharmaceuticals Basic Information List
Table 37. Bellicum Pharmaceuticals Description and Business Overview
Table 38. Bellicum Pharmaceuticals Engineered T Cells Products, Services and Solutions
Table 39. Revenue (US$ Million) in Engineered T Cells Business of Bellicum Pharmaceuticals (2019-2024)
Table 40. Bellicum Pharmaceuticals Recent Developments
Table 41. Cells Medica Basic Information List
Table 42. Cells Medica Description and Business Overview
Table 43. Cells Medica Engineered T Cells Products, Services and Solutions
Table 44. Revenue (US$ Million) in Engineered T Cells Business of Cells Medica (2019-2024)
Table 45. Cells Medica Recent Developments
Table 46. Elli Lilly and Company Basic Information List
Table 47. Elli Lilly and Company Description and Business Overview
Table 48. Elli Lilly and Company Engineered T Cells Products, Services and Solutions
Table 49. Revenue (US$ Million) in Engineered T Cells Business of Elli Lilly and Company (2019-2024)
Table 50. Elli Lilly and Company Recent Developments
Table 51. Gilead Sciences Basic Information List
Table 52. Gilead Sciences Description and Business Overview
Table 53. Gilead Sciences Engineered T Cells Products, Services and Solutions
Table 54. Revenue (US$ Million) in Engineered T Cells Business of Gilead Sciences (2019-2024)
Table 55. Gilead Sciences Recent Developments
Table 56. Juno Therapeutics Basic Information List
Table 57. Juno Therapeutics Description and Business Overview
Table 58. Juno Therapeutics Engineered T Cells Products, Services and Solutions
Table 59. Revenue (US$ Million) in Engineered T Cells Business of Juno Therapeutics (2019-2024)
Table 60. Juno Therapeutics Recent Developments
Table 61. Novartis Basic Information List
Table 62. Novartis Description and Business Overview
Table 63. Novartis Engineered T Cells Products, Services and Solutions
Table 64. Revenue (US$ Million) in Engineered T Cells Business of Novartis (2019-2024)
Table 65. Novartis Recent Developments
Table 66. Oxford Biomedica Basic Information List
Table 67. Oxford Biomedica Description and Business Overview
Table 68. Oxford Biomedica Engineered T Cells Products, Services and Solutions
Table 69. Revenue (US$ Million) in Engineered T Cells Business of Oxford Biomedica (2019-2024)
Table 70. Oxford Biomedica Recent Developments
Table 71. Pfizer Basic Information List
Table 72. Pfizer Description and Business Overview
Table 73. Pfizer Engineered T Cells Products, Services and Solutions
Table 74. Revenue (US$ Million) in Engineered T Cells Business of Pfizer (2019-2024)
Table 75. Pfizer Recent Developments
Table 76. Precision Bioscience Basic Information List
Table 77. Precision Bioscience Description and Business Overview
Table 78. Precision Bioscience Engineered T Cells Products, Services and Solutions
Table 79. Revenue (US$ Million) in Engineered T Cells Business of Precision Bioscience (2019-2024)
Table 80. Precision Bioscience Recent Developments
Table 81. Redmile Group Basic Information List
Table 82. Redmile Group Description and Business Overview
Table 83. Redmile Group Engineered T Cells Products, Services and Solutions
Table 84. Revenue (US$ Million) in Engineered T Cells Business of Redmile Group (2019-2024)
Table 85. Redmile Group Recent Developments
Table 86. Seeking Alpha Basic Information List
Table 87. Seeking Alpha Description and Business Overview
Table 88. Seeking Alpha Engineered T Cells Products, Services and Solutions
Table 89. Revenue (US$ Million) in Engineered T Cells Business of Seeking Alpha (2019-2024)
Table 90. Seeking Alpha Recent Developments
Table 91. Unum Therapeutics Basic Information List
Table 92. Unum Therapeutics Description and Business Overview
Table 93. Unum Therapeutics Engineered T Cells Products, Services and Solutions
Table 94. Revenue (US$ Million) in Engineered T Cells Business of Unum Therapeutics (2019-2024)
Table 95. Unum Therapeutics Recent Developments
Table 96. Key Raw Materials Lists
Table 97. Raw Materials Key Suppliers Lists
Table 98. Engineered T Cells Downstream Customers
Table 99. Engineered T Cells Distributors List
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Engineered T Cells Product Picture
Figure 2. Global Engineered T Cells Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Engineered T Cells Sales Value (2019-2030) & (US$ Million)
Figure 4. Engineered T Cells Report Years Considered
Figure 5. Global Engineered T Cells Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Engineered T Cells Revenue in 2023
Figure 7. Engineered T Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Tumor Infiltrating Lymphocytes Picture
Figure 9. T Cell Receptor {TCR} Picture
Figure 10. Chimeric Antigen Receptor(CAR) Picture
Figure 11. Global Engineered T Cells Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Engineered T Cells Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Hospitals
Figure 14. Product Picture of Cancer Research Centers
Figure 15. Product Picture of Clinics
Figure 16. Global Engineered T Cells Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Engineered T Cells Sales Value Market Share by Application, 2023 & 2030
Figure 18. North America Engineered T Cells Sales Value (2019-2030) & (US$ Million)
Figure 19. North America Engineered T Cells Sales Value by Country (%), 2023 VS 2030
Figure 20. Europe Engineered T Cells Sales Value (2019-2030) & (US$ Million)
Figure 21. Europe Engineered T Cells Sales Value by Country (%), 2023 VS 2030
Figure 22. Asia Pacific Engineered T Cells Sales Value (2019-2030) & (US$ Million)
Figure 23. Asia Pacific Engineered T Cells Sales Value by Country (%), 2023 VS 2030
Figure 24. South America Engineered T Cells Sales Value (2019-2030) & (US$ Million)
Figure 25. South America Engineered T Cells Sales Value by Country (%), 2023 VS 2030
Figure 26. Middle East & Africa Engineered T Cells Sales Value (2019-2030) & (US$ Million)
Figure 27. Middle East & Africa Engineered T Cells Sales Value by Country (%), 2023 VS 2030
Figure 28. Key Countries/Regions Engineered T Cells Sales Value (%), (2019-2030)
Figure 29. United States Engineered T Cells Sales Value, (2019-2030) & (US$ Million)
Figure 30. United States Engineered T Cells Sales Value by Type (%), 2023 VS 2030
Figure 31. United States Engineered T Cells Sales Value by Application (%), 2023 VS 2030
Figure 32. Europe Engineered T Cells Sales Value, (2019-2030) & (US$ Million)
Figure 33. Europe Engineered T Cells Sales Value by Type (%), 2023 VS 2030
Figure 34. Europe Engineered T Cells Sales Value by Application (%), 2023 VS 2030
Figure 35. China Engineered T Cells Sales Value, (2019-2030) & (US$ Million)
Figure 36. China Engineered T Cells Sales Value by Type (%), 2023 VS 2030
Figure 37. China Engineered T Cells Sales Value by Application (%), 2023 VS 2030
Figure 38. Japan Engineered T Cells Sales Value, (2019-2030) & (US$ Million)
Figure 39. Japan Engineered T Cells Sales Value by Type (%), 2023 VS 2030
Figure 40. Japan Engineered T Cells Sales Value by Application (%), 2023 VS 2030
Figure 41. South Korea Engineered T Cells Sales Value, (2019-2030) & (US$ Million)
Figure 42. South Korea Engineered T Cells Sales Value by Type (%), 2023 VS 2030
Figure 43. South Korea Engineered T Cells Sales Value by Application (%), 2023 VS 2030
Figure 44. Southeast Asia Engineered T Cells Sales Value, (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Engineered T Cells Sales Value by Type (%), 2023 VS 2030
Figure 46. Southeast Asia Engineered T Cells Sales Value by Application (%), 2023 VS 2030
Figure 47. India Engineered T Cells Sales Value, (2019-2030) & (US$ Million)
Figure 48. India Engineered T Cells Sales Value by Type (%), 2023 VS 2030
Figure 49. India Engineered T Cells Sales Value by Application (%), 2023 VS 2030
Figure 50. Engineered T Cells Industrial Chain
Figure 51. Engineered T Cells Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Table 1. Engineered T Cells Market Trends
Table 2. Engineered T Cells Market Drivers & Opportunity
Table 3. Engineered T Cells Market Challenges
Table 4. Engineered T Cells Market Restraints
Table 5. Global Engineered T Cells Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Engineered T Cells Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Engineered T Cells Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Engineered T Cells Product Type
Table 9. Key Companies Time to Begin Mass Production of Engineered T Cells
Table 10. Global Engineered T Cells Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Engineered T Cells as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Engineered T Cells Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Engineered T Cells Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Engineered T Cells Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Engineered T Cells Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Engineered T Cells Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Engineered T Cells Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Engineered T Cells Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Engineered T Cells Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Engineered T Cells Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Engineered T Cells Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Engineered T Cells Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Engineered T Cells Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Engineered T Cells Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Engineered T Cells Sales Value by Region (2019-2024) & (%)
Table 27. Global Engineered T Cells Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Engineered T Cells Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Engineered T Cells Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Engineered T Cells Sales Value, (2025-2030) & (US$ Million)
Table 31. Autolus Limited Basic Information List
Table 32. Autolus Limited Description and Business Overview
Table 33. Autolus Limited Engineered T Cells Products, Services and Solutions
Table 34. Revenue (US$ Million) in Engineered T Cells Business of Autolus Limited (2019-2024)
Table 35. Autolus Limited Recent Developments
Table 36. Bellicum Pharmaceuticals Basic Information List
Table 37. Bellicum Pharmaceuticals Description and Business Overview
Table 38. Bellicum Pharmaceuticals Engineered T Cells Products, Services and Solutions
Table 39. Revenue (US$ Million) in Engineered T Cells Business of Bellicum Pharmaceuticals (2019-2024)
Table 40. Bellicum Pharmaceuticals Recent Developments
Table 41. Cells Medica Basic Information List
Table 42. Cells Medica Description and Business Overview
Table 43. Cells Medica Engineered T Cells Products, Services and Solutions
Table 44. Revenue (US$ Million) in Engineered T Cells Business of Cells Medica (2019-2024)
Table 45. Cells Medica Recent Developments
Table 46. Elli Lilly and Company Basic Information List
Table 47. Elli Lilly and Company Description and Business Overview
Table 48. Elli Lilly and Company Engineered T Cells Products, Services and Solutions
Table 49. Revenue (US$ Million) in Engineered T Cells Business of Elli Lilly and Company (2019-2024)
Table 50. Elli Lilly and Company Recent Developments
Table 51. Gilead Sciences Basic Information List
Table 52. Gilead Sciences Description and Business Overview
Table 53. Gilead Sciences Engineered T Cells Products, Services and Solutions
Table 54. Revenue (US$ Million) in Engineered T Cells Business of Gilead Sciences (2019-2024)
Table 55. Gilead Sciences Recent Developments
Table 56. Juno Therapeutics Basic Information List
Table 57. Juno Therapeutics Description and Business Overview
Table 58. Juno Therapeutics Engineered T Cells Products, Services and Solutions
Table 59. Revenue (US$ Million) in Engineered T Cells Business of Juno Therapeutics (2019-2024)
Table 60. Juno Therapeutics Recent Developments
Table 61. Novartis Basic Information List
Table 62. Novartis Description and Business Overview
Table 63. Novartis Engineered T Cells Products, Services and Solutions
Table 64. Revenue (US$ Million) in Engineered T Cells Business of Novartis (2019-2024)
Table 65. Novartis Recent Developments
Table 66. Oxford Biomedica Basic Information List
Table 67. Oxford Biomedica Description and Business Overview
Table 68. Oxford Biomedica Engineered T Cells Products, Services and Solutions
Table 69. Revenue (US$ Million) in Engineered T Cells Business of Oxford Biomedica (2019-2024)
Table 70. Oxford Biomedica Recent Developments
Table 71. Pfizer Basic Information List
Table 72. Pfizer Description and Business Overview
Table 73. Pfizer Engineered T Cells Products, Services and Solutions
Table 74. Revenue (US$ Million) in Engineered T Cells Business of Pfizer (2019-2024)
Table 75. Pfizer Recent Developments
Table 76. Precision Bioscience Basic Information List
Table 77. Precision Bioscience Description and Business Overview
Table 78. Precision Bioscience Engineered T Cells Products, Services and Solutions
Table 79. Revenue (US$ Million) in Engineered T Cells Business of Precision Bioscience (2019-2024)
Table 80. Precision Bioscience Recent Developments
Table 81. Redmile Group Basic Information List
Table 82. Redmile Group Description and Business Overview
Table 83. Redmile Group Engineered T Cells Products, Services and Solutions
Table 84. Revenue (US$ Million) in Engineered T Cells Business of Redmile Group (2019-2024)
Table 85. Redmile Group Recent Developments
Table 86. Seeking Alpha Basic Information List
Table 87. Seeking Alpha Description and Business Overview
Table 88. Seeking Alpha Engineered T Cells Products, Services and Solutions
Table 89. Revenue (US$ Million) in Engineered T Cells Business of Seeking Alpha (2019-2024)
Table 90. Seeking Alpha Recent Developments
Table 91. Unum Therapeutics Basic Information List
Table 92. Unum Therapeutics Description and Business Overview
Table 93. Unum Therapeutics Engineered T Cells Products, Services and Solutions
Table 94. Revenue (US$ Million) in Engineered T Cells Business of Unum Therapeutics (2019-2024)
Table 95. Unum Therapeutics Recent Developments
Table 96. Key Raw Materials Lists
Table 97. Raw Materials Key Suppliers Lists
Table 98. Engineered T Cells Downstream Customers
Table 99. Engineered T Cells Distributors List
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Engineered T Cells Product Picture
Figure 2. Global Engineered T Cells Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Engineered T Cells Sales Value (2019-2030) & (US$ Million)
Figure 4. Engineered T Cells Report Years Considered
Figure 5. Global Engineered T Cells Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Engineered T Cells Revenue in 2023
Figure 7. Engineered T Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Tumor Infiltrating Lymphocytes Picture
Figure 9. T Cell Receptor {TCR} Picture
Figure 10. Chimeric Antigen Receptor(CAR) Picture
Figure 11. Global Engineered T Cells Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Engineered T Cells Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Hospitals
Figure 14. Product Picture of Cancer Research Centers
Figure 15. Product Picture of Clinics
Figure 16. Global Engineered T Cells Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Engineered T Cells Sales Value Market Share by Application, 2023 & 2030
Figure 18. North America Engineered T Cells Sales Value (2019-2030) & (US$ Million)
Figure 19. North America Engineered T Cells Sales Value by Country (%), 2023 VS 2030
Figure 20. Europe Engineered T Cells Sales Value (2019-2030) & (US$ Million)
Figure 21. Europe Engineered T Cells Sales Value by Country (%), 2023 VS 2030
Figure 22. Asia Pacific Engineered T Cells Sales Value (2019-2030) & (US$ Million)
Figure 23. Asia Pacific Engineered T Cells Sales Value by Country (%), 2023 VS 2030
Figure 24. South America Engineered T Cells Sales Value (2019-2030) & (US$ Million)
Figure 25. South America Engineered T Cells Sales Value by Country (%), 2023 VS 2030
Figure 26. Middle East & Africa Engineered T Cells Sales Value (2019-2030) & (US$ Million)
Figure 27. Middle East & Africa Engineered T Cells Sales Value by Country (%), 2023 VS 2030
Figure 28. Key Countries/Regions Engineered T Cells Sales Value (%), (2019-2030)
Figure 29. United States Engineered T Cells Sales Value, (2019-2030) & (US$ Million)
Figure 30. United States Engineered T Cells Sales Value by Type (%), 2023 VS 2030
Figure 31. United States Engineered T Cells Sales Value by Application (%), 2023 VS 2030
Figure 32. Europe Engineered T Cells Sales Value, (2019-2030) & (US$ Million)
Figure 33. Europe Engineered T Cells Sales Value by Type (%), 2023 VS 2030
Figure 34. Europe Engineered T Cells Sales Value by Application (%), 2023 VS 2030
Figure 35. China Engineered T Cells Sales Value, (2019-2030) & (US$ Million)
Figure 36. China Engineered T Cells Sales Value by Type (%), 2023 VS 2030
Figure 37. China Engineered T Cells Sales Value by Application (%), 2023 VS 2030
Figure 38. Japan Engineered T Cells Sales Value, (2019-2030) & (US$ Million)
Figure 39. Japan Engineered T Cells Sales Value by Type (%), 2023 VS 2030
Figure 40. Japan Engineered T Cells Sales Value by Application (%), 2023 VS 2030
Figure 41. South Korea Engineered T Cells Sales Value, (2019-2030) & (US$ Million)
Figure 42. South Korea Engineered T Cells Sales Value by Type (%), 2023 VS 2030
Figure 43. South Korea Engineered T Cells Sales Value by Application (%), 2023 VS 2030
Figure 44. Southeast Asia Engineered T Cells Sales Value, (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Engineered T Cells Sales Value by Type (%), 2023 VS 2030
Figure 46. Southeast Asia Engineered T Cells Sales Value by Application (%), 2023 VS 2030
Figure 47. India Engineered T Cells Sales Value, (2019-2030) & (US$ Million)
Figure 48. India Engineered T Cells Sales Value by Type (%), 2023 VS 2030
Figure 49. India Engineered T Cells Sales Value by Application (%), 2023 VS 2030
Figure 50. Engineered T Cells Industrial Chain
Figure 51. Engineered T Cells Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232